drugset / Trial / NCT00147589

A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.

NCT00147589

Phase 3 Completed 320 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy, safety, and toleration of eplerenone in the treatment of children aged 6 to 16 years with high blood pressure. The study will last approximately 10 weeks and about 320 patients will participate.

Timeline

Start
2004-09
Primary completion
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplerenone Unknown

Indications